KAI Pharmaceuticals VP of Risk Salaries in Corvallis, OR | Comparably
KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
89

KAI Pharmaceuticals VP of Risk Salaries in Corvallis, OR

The average KAI Pharmaceuticals VP of Risk in Corvallis, OR earns an estimated $142,419 annually. KAI Pharmaceuticals' VP of Risk compensation is $536 less than the US average for a VP of Risk.

In Corvallis, OR, The Legal Department at KAI Pharmaceuticals earns $13,927 more on average than the Business Development Department.

Last updated 5 years ago.

$46k
$85k
$116k
$143k
$194k
$250k
$142,419
Average Compensation
$142,419
avg. base

VP of Risk Salaries at KAI Pharmaceuticals

In Corvallis, OR, VPs of Risk earn $55,154 more than Contracts Specialists, and $47,615 less than Corporate Counsels.

General Counsel
$207k*
Corporate Counsel
$190k*
Contracts Specialist
$87k*
Paralegal
$68k*
* estimated salary

Compensation at KAI Pharmaceuticals by Department

In Corvallis, OR, The Legal Department averages $13,927 more than the Business Development Department, and $2,221 less than the Product Department

Product
$140,021 Avg. total comp.
+$2k
Legal
$137,800 Avg. total comp.
Business Development
$123,873 Avg. total comp.
-$14k

VP of Risk Compensation by Gender (All Companies)

The average female VP of Risk at companies similar size to KAI Pharmaceuticals reported making $104,000, while the average male VP of Risk at similar sized companies reported making $157,000.

VP of Risk Compensation by Ethnicity (All Companies)

The average Hispanic or Latino VP of Risk at companies similar size to KAI Pharmaceuticals reported making $160,000, while the average Caucasian VP of Risk at similar sized companies reported making $132,000.

How VPs of Risk at KAI Pharmaceuticals Rate Their Compensation

The majority of VPs of Risk at KAI Pharmaceuticals believe they're compensated fairly. 100% of VPs of Risk at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals

×
Rate your company